A Bayesian hierarchical pharmacodynamic model provides a more comprehensive assessment of drug-induced QTc prolongation compared to standard regulatory methods by incorporating exposure-effect relationships and physiological variability.
No takes yet. Share an insight, caveat, or question.
May enhance QTc assessment precision in drug development; leaves open effects on regulatory decisions or clinical practice.
Chain et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: